Biopharma Funding, Deals Fall Sharply in 2023 in ‘Strategic’ Shift: PitchBook

The biopharmaceutical industry will have raised $24 billion in venture capital funding across approximately 840 transactions by the end of 2023, a steep decline compared to the last three years, according to a new quarterly report by market data firm PitchBook launched Wednesday.